Wells Fargo & Company Brainstorm Cell Therapeutics Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 28,811 shares of BCLI stock, worth $51,859. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,811

Previous 29,110 1.03%

Holding current value

$51,859

Previous $16,000 43.75%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.34 - $0.74 $101 - $221	-299 Reduced 1.03%	28,811 $9,000
Q1 2024 May 10, 2024	SELL	$0.28 - $0.66 $216 - $509	-772 Reduced 2.58%	29,110 $16,000
Q4 2023 Feb 09, 2024	SELL	$0.15 - $0.4 $1,574 - $4,198	-10,495 Reduced 25.99%	29,882 $8,000
Q3 2023 Nov 13, 2023	BUY	$0.2 - $2.08 $604 - $6,287	3,023 Added 8.09%	40,377 $8,000
Q2 2023 Aug 15, 2023	BUY	$2.0 - $3.2 $25,092 - $40,147	12,546 Added 50.57%	37,354 $76,000
Q1 2023 May 12, 2023	BUY	$1.43 - $3.3 $7,059 - $16,292	4,937 Added 24.85%	24,808 $81,000
Q4 2022 Feb 13, 2023	SELL	$1.37 - $4.42 $701 - $2,263	-512 Reduced 2.51%	19,871 $32,000
Q3 2022 Nov 14, 2022	BUY	$2.55 - $4.42 $6,339 - $10,988	2,486 Added 13.89%	20,383 $90,000
Q2 2022 Aug 12, 2022	BUY	$2.71 - $3.6 $4,531 - $6,019	1,672 Added 10.31%	17,897 $50,000
Q1 2022 May 16, 2022	SELL	$2.92 - $4.19 $6,812 - $9,775	-2,333 Reduced 12.57%	16,225 $55,000
Q4 2021 Feb 14, 2022	BUY	$2.81 - $4.23 $15,106 - $22,740	5,376 Added 40.78%	18,558 $74,000
Q3 2021 Nov 15, 2021	BUY	$3.14 - $4.09 $1,180 - $1,537	376 Added 2.94%	13,182 $44,000
Q2 2021 Aug 16, 2021	SELL	$3.01 - $4.01 $53,463 - $71,225	-17,762 Reduced 58.11%	12,806 $49,000
Q1 2021 May 13, 2021	SELL	$3.46 - $7.88 $249,472 - $568,163	-72,102 Reduced 70.23%	30,568 $116,000
Q4 2020 Feb 09, 2021	BUY	$3.99 - $17.73 $140,364 - $623,723	35,179 Added 52.12%	102,670 $465,000
Q3 2020 Nov 05, 2020	BUY	$11.19 - $16.92 $91,299 - $138,050	8,159 Added 13.75%	67,491 $1.14 Million
Q2 2020 Aug 13, 2020	BUY	$4.42 - $12.66 $193,282 - $553,609	43,729 Added 280.26%	59,332 $665,000
Q1 2020 May 14, 2020	BUY	$4.01 - $8.88 $62,568 - $138,554	15,603 New	15,603 $73,000

Others Institutions Holding BCLI

# of Institutions

Shares Held

11.9M

Call Options Held

169K

Put Options Held

30.6K

View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $65.7M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

More about BCLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Brainstorm Cell Therapeutics Inc. Transaction History